June 2011
Monthly Prescribing Reference;Jun2011, Vol. 27 Issue 6, pA.14
The article presents news briefs related to U.S. pharmaceutical industry. The influenza virus vaccine, Fluzone Intradermal, has been approved for the active immunization of adults 18-64 years old. Lamictal XR, the lamotrigine extended-release tablets, from GlaxoSmithKline's has been approved for conversion to monotherapy in patients. Nexium IV from AstraZeneca PLC has gained an indication for use in children >1 month of age for the short-term treatment of Gastroesophageal reflux disease (GERD).


Related Articles

  • Fluarix Quadrivalent OK'd.  // Monthly Prescribing Reference;Jan2013, Vol. 29 Issue 1, pA14 

    The article offers information on the approval of a vaccine Fluarix Quadrivalent OK'd from the company GlaxoSmithKline for the immunization of patients to prevent disease caused by seasonal influenza virus subtypes A.

  • The Industry.  // Pharmaceutical Representative;Jul2009, Vol. 39 Issue 7, p7 

    The article offers news briefs related to pharmaceutical industry in the U.S. It reports on the agreement between GlaxoSmithKline and Concert Pharmaceuticals Inc. It notes that Pfizer Inc. has a pending acquisition of Wyeth. Novavax Inc. announces its collaboration with National Institutes of...

  • GASTROINTESTINAL TRACT: 9A Hyperacidity, GERD, and ulcers.  // MPR - Pharmacist's Edition;Fall2011, Vol. 5 Issue 3, p147 

    The article offers information on various drugs along with its prescriptions for hyperacidity, ulcers, and gastroesophageal reflux disease (GERD). It says that Axid from GlaxoSmithKline is for duodenal ulcer, but it can raise serums salicylate levels in aspirin patients. It states that Cytotec...

  • Pharmacy operators emphasize importance of flu shots.  // Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p37 

    The article reports on the importance of flu shots which has been stressed by pharmacy operators in the U.S.

  • Glaxo bird flu vaccine trials. Odriscoll, Cath // ICIS Chemical Business;4/10/2006, Vol. 1 Issue 14, p38 

    The article reports on clinical trials that started in April 2006 to test pandemic bird flu vaccines developed by GlaxoSmithKline. Trials of the two vaccines are designed to test their ability to enhance the body's immunity to the virulent H5N1 type of bird flu also linked to human cases of the...

  • Untitled.  // Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p11 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including the approval of the Food and Drug Administration (FDA) on the production and distribution of influenza vaccines in the country, the approval to use Boostrix vaccine from GlaxoSmithKline in tetanus...

  • Severe flu season tests retail Rx.  // Chain Drug Review;2/4/2013, Vol. 35 Issue 3, p1 

    The article offers information on several drug chains across the U.S. including Walgreen Co., CVS/pharmacy Inc. and Rite Aid Corp. which are equipping them with flu vaccine to prevent the increasing number of influenza cases.

  • A Dose of Immunity. Williamson, Lauren // InsideCounsel;Sep2009, Vol. 20 Issue 213, p14 

    The article reports that an amendment to the Public Readiness and Emergency Preparedness Act (PREP) in the U.S. has included a provision which prevents people from filing lawsuits against the vaccine's makers. U.S. Health and Human Services Secretary, Kathleen Sibelius encouraged the lawsuit...

  • DH agrees deal with GSK on vaccine. Mayor, Susan // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/17/2010, Vol. 340 Issue 7751, p830 

    The article reports on the decision of England's Department of Health (DH) to order the swine flu vaccine developed by GlaxoSmithKline (GSK).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics